Objective

Many concerned scientists have called for more rigorous evidence that commercial antibodies specifically bind the intended target. The International Working Group for Antibody Validation (IWGAV) has recommended best approaches for validating antibodies used in common research applications, and has published suggested guidelines that are intended to enhance antibody reproducibility. The IWGAV has suggested ‘pillars’ for validation of antibodies that would enhance confidence in their function in biomedical and immunodetection applications. 

In answer to calls for more stringent corroboration of immunodetection application-based antibody validation, we are pleased to offer, enhanced validation for many antibodies in our portfolio. Enhanced validation (EV) data that are now represented on our product pages align with several of the 2016 IWGAV guidelines for more rigorous specificity testing, and are available for those antibodies in our catalogue that carry the EV symbol.

As a leading provider of primary antibody products that are validated every day by your peers through the immense number of peer reviewed citations of the use of our antibodies. Industry leading quality control processes and application testing ensure that you can rely on our antibodies to provide the expected performance the first time and every time. In addition to our long-standing commitment to validation, we continue to expand and improve our processes by incorporating more rigorous validation strategies into the development of many of our antibody reagents.